HealthMedical Research
Experimental Pill Doubles Survival in Pancreatic Cancer
New oral drug daraxonrasib nearly doubled survival in metastatic pancreatic cancer patients, marking a breakthrough against one of the deadliest cancers.
—5 min read
Tag
1 article
New oral drug daraxonrasib nearly doubled survival in metastatic pancreatic cancer patients, marking a breakthrough against one of the deadliest cancers.